31 August 2026 The Manager Market Announcements Office Australian Securities Exchange Dear Manager, CORPORATE GOVERNANCE In accordance with the ASX Listing Rules, attached are the following: 1. Corporate Governance Statement 2. Appendix 4G This...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Australian patent for PromarkerEndo
- Change in substantial holding
- Proteomics signs national distribution deal with Healius
- US patent secured for PromarkerEndo
- Proteomics Strategic Plan
Later from Proteomics International Laboratories
- Appendix 4E and Annual Report
- PromarkerD and PromarkerEso Commercial Rollout Update
- Investor Presentation
- Notice of AGM Date
- PromarkerEndo Validation and Refinement Complete
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories